ID   INSL3_HUMAN             Reviewed;         131 AA.
AC   P51460; B4DZ72; G3XAG0; Q3KPI5; Q3KPI6; Q6YNB5; Q9UEA2; Q9UPH6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Insulin-like 3;
DE   AltName: Full=Leydig insulin-like peptide;
DE            Short=Ley-I-L;
DE   AltName: Full=Relaxin-like factor;
DE   Contains:
DE     RecName: Full=Insulin-like 3 B chain;
DE   Contains:
DE     RecName: Full=Insulin-like 3 A chain;
DE   Flags: Precursor;
GN   Name=INSL3; Synonyms=RLF, RLNL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-60.
RC   TISSUE=Testis;
RX   PubMed=8034302; DOI=10.1007/BF02272850;
RA   Burkhardt E., Adham I.M., Hobohm U., Murphy D., Sander C., Engel W.;
RT   "A human cDNA coding for the Leydig insulin-like peptide (Ley I-L).";
RL   Hum. Genet. 94:91-94(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-60.
RX   PubMed=8020942; DOI=10.1006/geno.1994.1121;
RA   Burkhardt E., Adham I.M., Brosig B., Gastmann A., Mattei M.-G.,
RA   Engel W.;
RT   "Structural organization of the porcine and human genes coding for a
RT   Leydig cell-specific insulin-like peptide (LEY I-L) and chromosomal
RT   localization of the human gene (INSL3).";
RL   Genomics 20:13-19(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=7852540; DOI=10.1210/jcem.80.2.7852540;
RA   Tashima L.S., Hieber A.D., Greenwood F.C., Bryant-Greenwood G.D.;
RT   "The human Leydig insulin-like (hLEY I-L) gene is expressed in the
RT   corpus luteum and trophoblast.";
RL   J. Clin. Endocrinol. Metab. 80:707-710(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RA   Lim H.N., Oakenfull E.A., Rajpert De Meyts E., Skakkebaek N.E.,
RA   Hughes I.A., Hawkins J.R., Farr C.J.;
RT   "A novel human relaxin-like factor: evidence for the evolution of new
RT   hormonal functions?";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-60.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-60.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 21-35.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   INTERACTION WITH LGR8.
RX   PubMed=12114498; DOI=10.1074/jbc.C200398200;
RA   Kumagai J., Hsu S.Y., Matsumi H., Roh J.-S., Fu P., Wade J.D.,
RA   Bathgate R.A.D., Hsueh A.J.W.;
RT   "INSL3/Leydig insulin-like peptide activates the LGR8 receptor
RT   important in testis descent.";
RL   J. Biol. Chem. 277:31283-31286(2002).
RN   [11]
RP   STRUCTURE BY NMR OF 25-55 AND 106-131, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=16867980; DOI=10.1074/jbc.M603829200;
RA   Rosengren K.J., Zhang S., Lin F., Daly N.L., Scott D.J., Hughes R.A.,
RA   Bathgate R.A., Craik D.J., Wade J.D.;
RT   "Solution structure and characterization of the LGR8 receptor binding
RT   surface of insulin-like peptide 3.";
RL   J. Biol. Chem. 281:28287-28295(2006).
RN   [12]
RP   STRUCTURE BY NMR OF 25-55 AND 106-131, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=19086273; DOI=10.1021/bi801412w;
RA   Bullesbach E.E., Hass M.A., Jensen M.R., Hansen D.F., Kristensen S.M.,
RA   Schwabe C., Led J.J.;
RT   "Solution structure of a conformationally restricted fully active
RT   derivative of the human relaxin-like factor.";
RL   Biochemistry 47:13308-13317(2008).
RN   [13]
RP   VARIANT ALA-60.
RX   PubMed=10729310; DOI=10.1093/molehr/6.4.298;
RA   Krausz C., Quintana-Murci L., Fellous M., Siffroi J.P., McElreavey K.;
RT   "Absence of mutations involving the INSL3 gene in human idiopathic
RT   cryptorchidism.";
RL   Mol. Hum. Reprod. 6:298-302(2000).
RN   [14]
RP   VARIANT CRYPTO LEU-93, AND VARIANT ALA-60.
RX   PubMed=11095425; DOI=10.1210/jcem.85.11.6935;
RA   Tomboc M., Lee P.A., Mitwally M.F., Schneck F.X., Bellinger M.,
RA   Witchel S.F.;
RT   "Insulin-like 3/relaxin-like factor gene mutations are associated with
RT   cryptorchidism.";
RL   J. Clin. Endocrinol. Metab. 85:4013-4018(2000).
RN   [15]
RP   VARIANT ALA-60.
RX   PubMed=10759163; DOI=10.1203/00006450-200004000-00020;
RA   Koskimies P., Virtanen H., Lindstroem M., Kaleva M., Poutanen M.,
RA   Huhtaniemi I., Toppari J.;
RT   "A common polymorphism in the human relaxin-like factor (RLF) gene: no
RT   relationship with cryptorchidism.";
RL   Pediatr. Res. 47:538-541(2000).
RN   [16]
RP   VARIANT CRYPTO CYS-102, AND VARIANT ALA-60.
RX   PubMed=11746019; DOI=10.1002/ajmg.1579.abs;
RA   Marin P., Ferlin A., Moro E., Rossi A., Bartoloni L., Rossato M.,
RA   Foresta C.;
RT   "Novel insulin-like 3 (INSL3) gene mutation associated with human
RT   cryptorchidism.";
RL   Am. J. Med. Genet. 103:348-349(2001).
RN   [17]
RP   VARIANTS GLY-24; LEU-43; SER-49; ALA-60 AND HIS-102.
RX   PubMed=11182749; DOI=10.1530/eje.0.1440129;
RA   Lim H.N., Raipert-de Meyts E., Skakkebaek N.E., Hawkins J.R.,
RA   Hughes I.A.;
RT   "Genetic analysis of the INSL3 gene in patients with maldescent of the
RT   testis.";
RL   Eur. J. Endocrinol. 144:129-137(2001).
RN   [18]
RP   VARIANT ALA-60.
RX   PubMed=11383919; DOI=10.1007/BF03343848;
RA   Marin P., Ferlin A., Moro E., Garolla A., Foresta C.;
RT   "Different insulin-like 3 (INSL3) gene mutations not associated with
RT   human cryptorchidism.";
RL   J. Endocrinol. Invest. 24:RC13-RC15(2001).
RN   [19]
RP   VARIANT ALA-60.
RX   PubMed=11380919; DOI=10.1046/j.1442-200x.2001.01390.x;
RA   Takahashi I., Takahashi T., Komatsu M., Matsuda J., Takada G.;
RT   "Ala/Thr60 variant of the Leydig insulin-like hormone is not
RT   associated with cryptorchidism in the Japanese population.";
RL   Pediatr. Int. 43:256-258(2001).
RN   [20]
RP   VARIANT CRYPTO LYS-110.
RX   PubMed=12601553; DOI=10.1007/s100380300012;
RA   Canto P., Escudero I., Soederlund D., Nishimura E., Carranza-Lira S.,
RA   Gutierrez J., Nava A., Mendez J.P.;
RT   "A novel mutation of the insulin-like 3 gene in patients with
RT   cryptorchidism.";
RL   J. Hum. Genet. 48:86-90(2003).
CC   -!- FUNCTION: Seems to play a role in testicular function. May be a
CC       trophic hormone with a role in testicular descent in fetal life.
CC       Is a ligand for LGR8 receptor.
CC   -!- SUBUNIT: Heterodimer of a B chain and an A chain linked by two
CC       disulfide bonds. {ECO:0000269|PubMed:16867980,
CC       ECO:0000269|PubMed:19086273}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51460-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51460-2; Sequence=VSP_045526;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in prenatal and postnatal Leydig
CC       cells. Found as well in the corpus luteum, trophoblast, fetal
CC       membranes and breast. {ECO:0000269|PubMed:7852540}.
CC   -!- DISEASE: Cryptorchidism (CRYPTO) [MIM:219050]: One of the most
CC       frequent congenital abnormalities in humans, involving 2-5% of
CC       male births. Cryptorchidism is associated with increased risk of
CC       infertility and testicular cancer. {ECO:0000269|PubMed:11095425,
CC       ECO:0000269|PubMed:11746019, ECO:0000269|PubMed:12601553}.
CC       Note=The disease may be caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the insulin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA52017.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S72482; AAB31371.1; -; mRNA.
DR   EMBL; X73637; CAA52017.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AY082014; AAL92559.1; -; mRNA.
DR   EMBL; AK302780; BAG63984.1; -; mRNA.
DR   EMBL; AC005952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007201; AAD22740.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84635.1; -; Genomic_DNA.
DR   EMBL; BC032810; AAH32810.1; -; mRNA.
DR   EMBL; BC053345; AAH53345.1; -; mRNA.
DR   EMBL; BC071706; AAH71706.1; -; mRNA.
DR   EMBL; BC106721; AAI06722.1; -; mRNA.
DR   EMBL; BC106722; AAI06723.1; -; mRNA.
DR   CCDS; CCDS12365.1; -. [P51460-1]
DR   CCDS; CCDS58655.1; -. [P51460-2]
DR   PIR; B53024; B53024.
DR   RefSeq; NP_001252516.1; NM_001265587.1. [P51460-2]
DR   RefSeq; NP_005534.2; NM_005543.3. [P51460-1]
DR   UniGene; Hs.37062; -.
DR   PDB; 2H8B; NMR; -; A=106-131, B=25-55.
DR   PDB; 2K6T; NMR; -; A=106-131, B=25-55.
DR   PDB; 2K6U; NMR; -; A=106-131, B=25-49.
DR   PDBsum; 2H8B; -.
DR   PDBsum; 2K6T; -.
DR   PDBsum; 2K6U; -.
DR   ProteinModelPortal; P51460; -.
DR   SMR; P51460; -.
DR   BioGrid; 109851; 9.
DR   IntAct; P51460; 1.
DR   STRING; 9606.ENSP00000321724; -.
DR   BioMuta; INSL3; -.
DR   DMDM; 317373369; -.
DR   PaxDb; P51460; -.
DR   PeptideAtlas; P51460; -.
DR   PRIDE; P51460; -.
DR   Ensembl; ENST00000317306; ENSP00000321724; ENSG00000248099. [P51460-1]
DR   Ensembl; ENST00000379695; ENSP00000369017; ENSG00000248099. [P51460-2]
DR   GeneID; 3640; -.
DR   KEGG; hsa:3640; -.
DR   UCSC; uc002nhm.3; human. [P51460-1]
DR   CTD; 3640; -.
DR   DisGeNET; 3640; -.
DR   GeneCards; INSL3; -.
DR   H-InvDB; HIX0014900; -.
DR   HGNC; HGNC:6086; INSL3.
DR   HPA; HPA028615; -.
DR   MalaCards; INSL3; -.
DR   MIM; 146738; gene.
DR   MIM; 219050; phenotype.
DR   neXtProt; NX_P51460; -.
DR   OpenTargets; ENSG00000248099; -.
DR   PharmGKB; PA29893; -.
DR   eggNOG; ENOG410J0IS; Eukaryota.
DR   eggNOG; ENOG411140J; LUCA.
DR   GeneTree; ENSGT00510000050366; -.
DR   HOGENOM; HOG000113077; -.
DR   HOVERGEN; HBG052133; -.
DR   InParanoid; P51460; -.
DR   KO; K05255; -.
DR   OMA; CCSGWRD; -.
DR   OrthoDB; EOG091G128J; -.
DR   PhylomeDB; P51460; -.
DR   TreeFam; TF106361; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-444821; Relaxin receptors.
DR   EvolutionaryTrace; P51460; -.
DR   GeneWiki; INSL3; -.
DR   GenomeRNAi; 3640; -.
DR   PRO; PR:P51460; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000248099; -.
DR   CleanEx; HS_INSL3; -.
DR   CleanEx; HS_RLF; -.
DR   ExpressionAtlas; P51460; baseline and differential.
DR   Genevisible; P51460; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0005158; F:insulin receptor binding; TAS:ProtInc.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IDA:CACAO.
DR   GO; GO:0090303; P:positive regulation of wound healing; IDA:CACAO.
DR   GO; GO:0007283; P:spermatogenesis; TAS:ProtInc.
DR   Gene3D; 1.10.100.10; -; 1.
DR   InterPro; IPR016179; Insulin-like.
DR   InterPro; IPR022353; Insulin_CS.
DR   Pfam; PF00049; Insulin; 1.
DR   SMART; SM00078; IlGF; 1.
DR   SUPFAM; SSF56994; SSF56994; 2.
DR   PROSITE; PS00262; INSULIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Hormone;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:15340161}.
FT   PEPTIDE      21     55       Insulin-like 3 B chain.
FT                                /FTId=PRO_0000016140.
FT   PROPEP       58    104       C peptide like. {ECO:0000255}.
FT                                /FTId=PRO_0000016141.
FT   PEPTIDE     106    131       Insulin-like 3 A chain.
FT                                /FTId=PRO_0000016142.
FT   DISULFID     34    116       Interchain (between B and A chains).
FT   DISULFID     46    129       Interchain (between B and A chains).
FT   DISULFID    115    120
FT   VAR_SEQ      64    131       RELLQWLERRHLLHGLVADSNLTLGPGLQPLPQTSHHHRHH
FT                                RAAATNPARYCCLSGCTQQDLLTLCPY -> QRESHSVSQA
FT                                GLKLLSSSNPPTLTFQSVGISDVSCYSGWRDDICSMGWWPT
FT                                VISRWDLACSPCPRPLTITATTVQLPPTLHATAASVAVPNK
FT                                TC (in isoform 2). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045526.
FT   VARIANT      24     24       A -> G (in dbSNP:rs186828508).
FT                                {ECO:0000269|PubMed:11182749}.
FT                                /FTId=VAR_013231.
FT   VARIANT      43     43       V -> L. {ECO:0000269|PubMed:11182749}.
FT                                /FTId=VAR_013232.
FT   VARIANT      49     49       P -> S (could be a rare polymorphism;
FT                                identified in a male with
FT                                undermasculinised genitalia and intra-
FT                                abdominal testes; dbSNP:rs751299877).
FT                                {ECO:0000269|PubMed:11182749}.
FT                                /FTId=VAR_013233.
FT   VARIANT      60     60       T -> A (common polymorphism;
FT                                dbSNP:rs6523).
FT                                {ECO:0000269|PubMed:10729310,
FT                                ECO:0000269|PubMed:10759163,
FT                                ECO:0000269|PubMed:11095425,
FT                                ECO:0000269|PubMed:11182749,
FT                                ECO:0000269|PubMed:11380919,
FT                                ECO:0000269|PubMed:11383919,
FT                                ECO:0000269|PubMed:11746019,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8020942,
FT                                ECO:0000269|PubMed:8034302}.
FT                                /FTId=VAR_013234.
FT   VARIANT      93     93       P -> L (in CRYPTO; dbSNP:rs104894697).
FT                                {ECO:0000269|PubMed:11095425}.
FT                                /FTId=VAR_013235.
FT   VARIANT     102    102       R -> C (in CRYPTO; dbSNP:rs104894698).
FT                                {ECO:0000269|PubMed:11746019}.
FT                                /FTId=VAR_013236.
FT   VARIANT     102    102       R -> H (in dbSNP:rs121912556).
FT                                {ECO:0000269|PubMed:11182749}.
FT                                /FTId=VAR_013237.
FT   VARIANT     110    110       N -> K (in CRYPTO; dbSNP:rs121912555).
FT                                {ECO:0000269|PubMed:12601553}.
FT                                /FTId=VAR_017122.
FT   HELIX        36     46       {ECO:0000244|PDB:2H8B}.
FT   TURN         48     50       {ECO:0000244|PDB:2H8B}.
FT   HELIX       111    117       {ECO:0000244|PDB:2H8B}.
FT   HELIX       122    126       {ECO:0000244|PDB:2H8B}.
SQ   SEQUENCE   131 AA;  14502 MW;  94788D700524C12A CRC64;
     MDPRLPAWAL VLLGPALVFA LGPAPTPEMR EKLCGHHFVR ALVRVCGGPR WSTEARRPAT
     GGDRELLQWL ERRHLLHGLV ADSNLTLGPG LQPLPQTSHH HRHHRAAATN PARYCCLSGC
     TQQDLLTLCP Y
//
